Multiple Myeloma in Relapse Active Not Recruiting Phase 1 Trials for Lenalidomide (DB00480)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01965353A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple MyelomaTreatment